Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of SIRT1 activators or inhibitors to modulate an immune response

Use of SIRT1 activators or inhibitors to modulate an immune response

US Patent 8748464 · Granted Jun 10, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl amide inhibitors of CD382025
Chimeric antigen receptors and uses thereof2025
HIV or HCV detection with CRISPR-CAS13A2025
Compositions and methods for immunooncology2023
Compositions and methods for reactivating latent immunodeficiency virus2023
S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same2023
Hematopoietic stem cell engraftment2023
Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compos2023
Compositions and methods for reactivating latent immunodeficiency virus2021
Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compos2021
Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compos2020
Medium chain fatty acid esters of β-hydroxybutyrate and butanediol and compositi2020